Clinical Experience of Using 0.2 % Olopatadin in the Allergic Conjunctivitis Treatment

Benzer Materyaller

• Our Experience Olopatadine Treatment of Allergic Conjunctivitis in Children
  Yazar:: T. N. Vorontsova, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-07-01)
• Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis
  Yazar:: Lakshey Dudeja, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-01-01)
• Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis
  Yazar:: Ayyappanavar, Shruti, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies
  Yazar:: Epstein, Arthur B, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
  Yazar:: Mizoguchi, Takanori, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)